导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.46% | 536/1050 |
| 近一周 | -3.21% | 838/1104 |
| 近一月 | -5.07% | 616/1102 |
| 近一季 | -7.93% | 578/1092 |
| 近半年 | -5.07% | 607/1070 |
| 近一年 | 23.16% | 208/1018 |
| 近两年 | 95.67% | 210/926 |
| 近三年 | 65.40% | 175/834 |
| 成立以来 | 128.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.34% 394/1070 |
9.91% 543/1101 |
- - |
- - |
| 2025 | 57.43% 129/1065 |
1.31% 700/1014 |
6.83% 201/1038 |
47.41% 103/1050 |
-1.32% 519/1065 |
| 2024 | 10.02% 288/1011 |
0.88% 270/960 |
2.62% 167/983 |
9.06% 705/991 |
-2.56% 492/1011 |
| 2023 | -14.76% 515/952 |
5.67% 277/880 |
-6.47% 609/895 |
-10.17% 595/915 |
-4.00% 409/952 |
| 2022 | -21.09% 373/867 |
-18.07% 430/773 |
12.24% 184/806 |
-15.01% 567/845 |
0.97% 386/867 |
| 2021 | 17.27% 167/740 |
-2.34% 233/580 |
10.62% 338/659 |
3.16% 160/704 |
5.22% 214/740 |
| 2020 | 34.44% 331/554 |
-13.61% 400/419 |
11.71% 388/466 |
11.81% 210/517 |
24.59% 72/554 |
| 2019 | 52.93% 129/410 |
46.29% 20/1146 |
-1.78% 506/1228 |
2.44% 267/390 |
3.89% 365/410 |
| 2018 | -19.56% 67/349 |
- - |
-8.66% 404/990 |
0.70% 151/1000 |
-10.58% 339/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 诺安高端制造股票A VS. 东吴新产业精选股票A(580008) |